Cargando…

Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis

SIMPLE SUMMARY: The impact of the co-occurrence of coronary artery disease and hematologic malignancies (HM) remains poorly understood. Therefore, the aim of this analysis was to clarify how HM affects the prognosis of acute coronary syndrome (ACS). To this end, we analyzed 439,716 patients hospital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lange, Stefan A., Schliemann, Christoph, Engelbertz, Christiane, Feld, Jannik, Makowski, Lena, Gerß, Joachim, Dröge, Patrik, Ruhnke, Thomas, Günster, Christian, Reinecke, Holger, Köppe, Jeanette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605274/ https://www.ncbi.nlm.nih.gov/pubmed/37894332 http://dx.doi.org/10.3390/cancers15204966

Ejemplares similares

Contemporary secondary prevention in survivors of ST-elevation myocardial infarction with and without chronic kidney disease: a retrospective analysis
por: Engelbertz, Christiane, et al.
Publicado: (2023)

Acute and Long-Term Outcomes of ST-Elevation Myocardial Infarction in Cancer Patients, a ‘Real World’ Analysis with 175,000 Patients
por: Lange, Stefan A., et al.
Publicado: (2021)

Sex-related differences in treatment and outcome of chronic limb-threatening ischaemia: a real-world cohort
por: Makowski, Lena, et al.
Publicado: (2022)

Contemporary in-hospital and long-term prognosis of patients with acute ST-elevation myocardial infarction depending on renal function: a retrospective analysis
por: Engelbertz, Christiane, et al.
Publicado: (2023)

Depression and Anxiety in Heart Transplant Recipients: Prevalence and Impact on Post-Transplant Outcomes
por: Alyaydin, Emyal, et al.
Publicado: (2023)

Association of age with 1-year outcome in patients with acute ischaemic stroke treated with thrombectomy: real-world analysis in 18 506 patients
por: Beuker, Carolin, et al.
Publicado: (2023)

Outcome in octogenarian patients with lower extremity artery disease after endovascular revascularisation: a retrospective single-centre cohort study using in-patient data
por: Lakomek, Antonia, et al.
Publicado: (2022)

Gender differences in acute myocardial infarction—A nationwide German real‐life analysis from 2014 to 2017
por: Kuehnemund, Leonie, et al.
Publicado: (2021)

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
por: Reinecke, Holger, et al.
Publicado: (2018)

Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis
por: Freisinger, Eva, et al.
Publicado: (2019)

Unmet medical needs in intermittent Claudication with diabetes and coronary artery disease—A “real‐world” analysis on 21 197 PAD patients
por: Stalling, Philipp, et al.
Publicado: (2019)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Admission Rates, Time Trends, Risk Factors, and Outcomes of Ischemic and Hemorrhagic Stroke From German Nationwide Data
por: Kelly, Dearbhla M., et al.
Publicado: (2022)

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
por: Reinecke, Holger, et al.
Publicado: (2022)

Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario
por: Krekeler, Carolin, et al.
Publicado: (2022)

Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures
por: Hetrodt, Johanna, et al.
Publicado: (2021)

Status Quo – Die Anforderungen an die medizinische Habilitation in Deutschland
por: Strauss, Markus, et al.
Publicado: (2020)

Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies
por: Ocon, Anthony J., et al.
Publicado: (2022)

Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence
por: Mueller, Linda, et al.
Publicado: (2022)

Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study
por: Valbert, Frederik, et al.
Publicado: (2023)

Indication for spinal surgery: associated factors and regional differences in Germany
por: Tesch, Falko, et al.
Publicado: (2022)

Medikamentöse Sekundärprävention bei Patienten mit peripherer arterieller Verschlusskrankheit: Eine sekundärdatenbasierte Analyse
por: Gebauer, Katrin, et al.
Publicado: (2020)

Socioeconomic differences in the utilization of diagnostic imaging and non-pharmaceutical conservative therapies for spinal diseases
por: Tesch, Falko, et al.
Publicado: (2023)

Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)
por: Reinecke, Holger, et al.
Publicado: (2016)

Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry
por: Engelbertz, Christiane, et al.
Publicado: (2021)

Routinedaten aus Notaufnahmen: Unterschiedliche Dokumentationsanforderungen, Abrechnungsmodalitäten und Datenhalter bei identischem Ort der Leistungserbringung
por: Greiner, Felix, et al.
Publicado: (2020)

Editorial: Real-World evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2022)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2019)

The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study
por: Dar, Lior, et al.
Publicado: (2021)

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
por: Yahalom, Joachim, et al.
Publicado: (2020)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study
por: Habbous, Steven, et al.
Publicado: (2020)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_24ni2741hlto9lufr5aq0h3o20